333 related articles for article (PubMed ID: 27438114)
21. Septal myectomy for hypertrophic cardiomyopathy: important surgical knowledge and technical tips in the era of increasing alcohol septal ablation.
Chiang YP; Shimada YJ; Ginns J; Weiner SD; Takayama H
Gen Thorac Cardiovasc Surg; 2018 Apr; 66(4):192-200. PubMed ID: 29450766
[TBL] [Abstract][Full Text] [Related]
22. Predictors of long-term outcome after septal myectomy in symptomatic hypertrophic obstructive cardiomyopathy patients with previous alcohol septal ablation and residual obstruction.
Zhu C; Tang B; Cui H; Wang S; Xiao M; Chen Z; Meng Y; Zhao S; Song Y; Yu Q; Wang S
J Card Surg; 2019 Jul; 34(7):533-540. PubMed ID: 31111576
[TBL] [Abstract][Full Text] [Related]
23. Outcomes of Alcohol Septal Ablation in Younger Patients With Obstructive Hypertrophic Cardiomyopathy.
Liebregts M; Faber L; Jensen MK; Vriesendorp PA; Januska J; Krejci J; Hansen PR; Seggewiss H; Horstkotte D; Adlova R; Bundgaard H; Ten Berg JM; Veselka J
JACC Cardiovasc Interv; 2017 Jun; 10(11):1134-1143. PubMed ID: 28595881
[TBL] [Abstract][Full Text] [Related]
24. Meta-analyses of septal reduction therapies for obstructive hypertrophic cardiomyopathy: comparative rates of overall mortality and sudden cardiac death after treatment.
Leonardi RA; Kransdorf EP; Simel DL; Wang A
Circ Cardiovasc Interv; 2010 Apr; 3(2):97-104. PubMed ID: 20197511
[TBL] [Abstract][Full Text] [Related]
25. Septal Myectomy in Hypertrophic Cardiomyopathy: National Outcomes of Concomitant Mitral Surgery.
Holst KA; Hanson KT; Ommen SR; Nishimura RA; Habermann EB; Schaff HV
Mayo Clin Proc; 2019 Jan; 94(1):66-73. PubMed ID: 30611455
[TBL] [Abstract][Full Text] [Related]
26. Comparison of Surgical Ventricular Septal Reduction to Alcohol Septal Ablation Therapy in Patients with Hypertrophic Cardiomyopathy.
Bourque C; Réant P; Bernard A; Leroux L; Bonnet G; Pernot M; Bisson A; Herbert J; Saint-Etienne C; Lafitte S; Fauchier L
Am J Cardiol; 2022 Jun; 172():109-114. PubMed ID: 35351287
[TBL] [Abstract][Full Text] [Related]
27. Costs and Healthcare Resource Utilization for Obstructive Hypertrophic Cardiomyopathy With Septal Reduction Therapy.
Butzner M; Maron MS; Sarocco P; Teng CC; Stanek E; Tan H; Robertson LA
J Invasive Cardiol; 2022 Dec; 34(12):E866-E872. PubMed ID: 36288089
[TBL] [Abstract][Full Text] [Related]
28. Surgical Outcomes of Septal Myectomy With and Without Mitral Valve Surgeries in Hypertrophic Cardiomyopathy: a National Propensity-Matched Analysis (2005 to 2020).
Faisaluddin M; Ahmed A; Patel H; Thakkar S; Patel B; Balasubramanian S; Feitell SC; Shekar P; Rowin E; Maron M; Ganatra S; Dani SS
Am J Cardiol; 2023 Oct; 205():276-282. PubMed ID: 37619494
[TBL] [Abstract][Full Text] [Related]
29. Survival Following Alcohol Septal Ablation or Septal Myectomy for Patients With Obstructive Hypertrophic Cardiomyopathy.
Cui H; Schaff HV; Wang S; Lahr BD; Rowin EJ; Rastegar H; Hu S; Eleid MF; Dearani JA; Kimmelstiel C; Maron BJ; Nishimura RA; Ommen SR; Maron MS
J Am Coll Cardiol; 2022 May; 79(17):1647-1655. PubMed ID: 35483751
[TBL] [Abstract][Full Text] [Related]
30. Low incidence of procedure-related major adverse cardiac events after alcohol septal ablation for symptomatic hypertrophic obstructive cardiomyopathy.
Veselka J; Lawrenz T; Stellbrink C; Zemanek D; Branny M; Januska J; Groch L; Dimitrow P; Krejci J; Dabrowski M; Mizera S; Kuhn H
Can J Cardiol; 2013 Nov; 29(11):1415-21. PubMed ID: 23927866
[TBL] [Abstract][Full Text] [Related]
31. The long-term outcomes of transcoronary ablation of septal hypertrophy compared to surgical myectomy in patients with symptomatic hypertrophic obstructive cardiomyopathy.
Samardhi H; Walters DL; Raffel C; Rateesh S; Harley C; Burstow D; Pohlner P; Aroney C
Catheter Cardiovasc Interv; 2014 Feb; 83(2):270-7. PubMed ID: 23873660
[TBL] [Abstract][Full Text] [Related]
32. Hypertrophic obstructive cardiomyopathy-alcohol septal ablation vs. myectomy: a meta-analysis.
Alam M; Dokainish H; Lakkis NM
Eur Heart J; 2009 May; 30(9):1080-7. PubMed ID: 19233857
[TBL] [Abstract][Full Text] [Related]
33. Alcohol septal ablation versus surgical septal myectomy of obstructive hypertrophic cardiomyopathy: systematic review and meta-analysis.
Yokoyama Y; Shimoda T; Shimada YJ; Shimamura J; Akita K; Yasuda R; Takayama H; Kuno T
Eur J Cardiothorac Surg; 2023 Mar; 63(3):. PubMed ID: 36782361
[TBL] [Abstract][Full Text] [Related]
34. Septal myectomy after failed alcohol ablation: Does previous percutaneous intervention compromise outcomes of myectomy?
Quintana E; Sabate-Rotes A; Maleszewski JJ; Ommen SR; Nishimura RA; Dearani JA; Schaff HV
J Thorac Cardiovasc Surg; 2015 Jul; 150(1):159-67.e1. PubMed ID: 25940414
[TBL] [Abstract][Full Text] [Related]
35. Impact of Hospital Volume on Outcomes of Septal Myectomy for Hypertrophic Cardiomyopathy.
Holst KA; Schaff HV; Smedira NG; Habermann EB; Day CN; Badhwar V; Takayama H; McCarthy PM; Dearani JA
Ann Thorac Surg; 2022 Dec; 114(6):2131-2138. PubMed ID: 35779600
[TBL] [Abstract][Full Text] [Related]
36. Alcohol septal ablation: A useful tool in our arsenal against hypertrophic obstructive cardiomyopathy.
Savarimuthu S; Harky A
J Card Surg; 2020 Aug; 35(8):2017-2024. PubMed ID: 32652778
[TBL] [Abstract][Full Text] [Related]
37. Long-term clinical follow-up of patients undergoing percutaneous alcohol septal reduction for symptomatic obstructive hypertrophic cardiomyopathy.
Fortunato de Cano S; Nicolas Cano M; de Ribamar Costa J; Alves Pinheiro J; Bellio de Mattos Barretto R; Costa de Souza Le Bihan D; Abizaid A; Sousa A; Eduardo Sousa J
Catheter Cardiovasc Interv; 2016 Nov; 88(6):953-960. PubMed ID: 27143093
[TBL] [Abstract][Full Text] [Related]
38. Updated meta-analysis of septal alcohol ablation versus myectomy for hypertrophic cardiomyopathy.
Agarwal S; Tuzcu EM; Desai MY; Smedira N; Lever HM; Lytle BW; Kapadia SR
J Am Coll Cardiol; 2010 Feb; 55(8):823-34. PubMed ID: 20170823
[TBL] [Abstract][Full Text] [Related]
39. Volume-outcome relationship in septal myectomy for hypertrophic obstructive cardiomyopathy.
Hadaya J; Verma A; Sanaiha Y; Shemin RJ; Benharash P
Surgery; 2023 Aug; 174(2):166-171. PubMed ID: 37230867
[TBL] [Abstract][Full Text] [Related]
40. Septal Ablation and Hypertrophic Obstructive Cardiomyopathy: 7 Years US Experience.
Chothani A; Panaich SS; Patel N; Patel NJ; Arora S; Deshmukh A; Grines C; Badheka AO
J Interv Cardiol; 2016 Oct; 29(5):505-512. PubMed ID: 27545515
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
